These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29229526)

  • 1. An oligothiophene compound neutralized influenza A viruses by interfering with hemagglutinin.
    Shen X; Zhu Z; Ding Y; Wu W; Yang J; Liu S
    Biochim Biophys Acta Biomembr; 2018 Mar; 1860(3):784-791. PubMed ID: 29229526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligothiophene compounds inhibit the membrane fusion between H5N1 avian influenza virus and the endosome of host cell.
    Zhu Z; Yao Z; Shen X; Chen Z; Liu X; Parquette JR; Liu S
    Eur J Med Chem; 2017 Apr; 130():185-194. PubMed ID: 28246043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermonomer Interactions in Hemagglutinin Subunits HA1 and HA2 Affecting Hemagglutinin Stability and Influenza Virus Infectivity.
    Wang W; DeFeo CJ; Alvarado-Facundo E; Vassell R; Weiss CD
    J Virol; 2015 Oct; 89(20):10602-11. PubMed ID: 26269180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry.
    Liu S; Li R; Zhang R; Chan CC; Xi B; Zhu Z; Yang J; Poon VK; Zhou J; Chen M; Münch J; Kirchhoff F; Pleschka S; Haarmann T; Dietrich U; Pan C; Du L; Jiang S; Zheng B
    Eur J Pharmacol; 2011 Jun; 660(2-3):460-7. PubMed ID: 21536025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Oleanolic Acid Derivative Inhibits Hemagglutinin-Mediated Entry of Influenza A Virus.
    Ye M; Liao Y; Wu L; Qi W; Choudhry N; Liu Y; Chen W; Song G; Chen J
    Viruses; 2020 Feb; 12(2):. PubMed ID: 32085430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors.
    Wang H; Xu R; Shi Y; Si L; Jiao P; Fan Z; Han X; Wu X; Zhou X; Yu F; Zhang Y; Zhang L; Zhang L; Zhou D; Xiao S
    Eur J Med Chem; 2016 Mar; 110():376-88. PubMed ID: 26866456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of 4-Aminopiperidines as Inhibitors of Influenza A Viral Entry That Are Synergistic with Oseltamivir.
    Gaisina IN; Peet NP; Cheng H; Li P; Du R; Cui Q; Furlong K; Manicassamy B; Caffrey M; Thatcher GRJ; Rong L
    J Med Chem; 2020 Mar; 63(6):3120-3130. PubMed ID: 32069052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
    Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
    Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y
    Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
    Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
    J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of 3-O-β-chacotriosyl oleanane-type triterpenoids as potential H5N1 entry inhibitors.
    Song G; Shen X; Li S; Li Y; Si H; Fan J; Li J; Gao E; Liu S
    Eur J Med Chem; 2016 Aug; 119():109-21. PubMed ID: 27153348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on the Antiviral Activities and Hemagglutinin-Based Molecular Mechanism of Novel Chlorogenin 3-
    Shi WZ; Jiang LZ; Song GP; Wang S; Xiong P; Ke CW
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32168921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a Biologically Contained Reporter System To Study Gain-of-Function H5N1 Influenza A Viruses with Pandemic Potential.
    Spieler EE; Moritz E; Stertz S; Hale BG
    mSphere; 2020 Aug; 5(4):. PubMed ID: 32848003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An influenza A hemagglutinin small-molecule fusion inhibitor identified by a new high-throughput fluorescence polarization screen.
    Yao Y; Kadam RU; Lee CD; Woehl JL; Wu NC; Zhu X; Kitamura S; Wilson IA; Wolan DW
    Proc Natl Acad Sci U S A; 2020 Aug; 117(31):18431-18438. PubMed ID: 32690700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of amino acids-oleanolic acid conjugates as influenza virus inhibitors.
    Meng L; Su Y; Yang F; Xiao S; Yin Z; Liu J; Zhong J; Zhou D; Yu F
    Bioorg Med Chem; 2019 Dec; 27(23):115147. PubMed ID: 31635892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral activity of stachyflin on influenza A viruses of different hemagglutinin subtypes.
    Motohashi Y; Igarashi M; Okamatsu M; Noshi T; Sakoda Y; Yamamoto N; Ito K; Yoshida R; Kida H
    Virol J; 2013 Apr; 10():118. PubMed ID: 23587221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-benzyl 4,4-disubstituted piperidines as a potent class of influenza H1N1 virus inhibitors showing a novel mechanism of hemagglutinin fusion peptide interaction.
    de Castro S; Ginex T; Vanderlinden E; Laporte M; Stevaert A; Cumella J; Gago F; Camarasa MJ; Luque FJ; Naesens L; Velazquez S
    Eur J Med Chem; 2020 May; 194():112223. PubMed ID: 32220685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Super short membrane-active lipopeptides inhibiting the entry of influenza A virus.
    Wu W; Wang J; Lin D; Chen L; Xie X; Shen X; Yang Q; Wu Q; Yang J; He J; Liu S
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt A):2344-50. PubMed ID: 26092189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of privileged structures into 3-O-β-chacotriosyl ursolic acid can enhance inhibiting the entry of the H5N1 virus.
    Li H; Chen L; Li S; Liao Y; Wang L; Liu Z; Liu S; Song G
    Bioorg Med Chem Lett; 2019 Sep; 29(18):2675-2680. PubMed ID: 31371135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins.
    Marjuki H; Mishin VP; Chai N; Tan MW; Newton EM; Tegeris J; Erlandson K; Willis M; Jones J; Davis T; Stevens J; Gubareva LV
    J Virol; 2016 Dec; 90(23):10446-10458. PubMed ID: 27630240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.